Research ArticleNuclear Oncology
Preclinical Characterization and In Vivo Imaging Studies of an Engineered Recombinant Technetium-99m-Labeled Metallothionein-Containing Anti-Carcinoembryonic Antigen Single-Chain Antibody
Geoffrey A. Pietersz, Mark R. Patrick and Kerry A. Chester
Journal of Nuclear Medicine January 1998, 39 (1) 47-56;
Geoffrey A. Pietersz
Mark R. Patrick
This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Preclinical Characterization and In Vivo Imaging Studies of an Engineered Recombinant Technetium-99m-Labeled Metallothionein-Containing Anti-Carcinoembryonic Antigen Single-Chain Antibody
Geoffrey A. Pietersz, Mark R. Patrick, Kerry A. Chester
Journal of Nuclear Medicine Jan 1998, 39 (1) 47-56;
Jump to section
Related Articles
- No related articles found.
Cited By...
- Imaging of Tumor Angiogenesis Using 99mTc-Labeled Human Recombinant Anti-ED-B Fibronectin Antibody Fragments
- Biodistribution Properties of 111Indium-labeled C-Functionalized trans-Cyclohexyl Diethylenetriaminepentaacetic Acid Humanized 3S193 Diabody and F(ab')2 Constructs in a Breast Carcinoma Xenograft Model
- In Vivo Targeting of Malignant Melanoma by 125Iodine- and 99mTechnetium-labeled Single-chain Fv Fragments against High Molecular Weight Melanoma-associated Antigen